New Zealand markets closed

Talis Biomedical Corporation (TLIS)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
9.14+0.25 (+2.81%)
At close: 04:00PM EDT
9.00 -0.14 (-1.53%)
After hours: 06:59PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
412
412
3,652
0
0
Cost of revenue
41
41
8,391
0
-
Gross profit
371
371
-4,739
0
-
Operating expenses
Research development
40,694
40,694
70,831
157,591
89,019
Selling general and administrative
28,214
28,214
40,729
42,418
13,103
Total operating expenses
67,186
67,186
110,400
191,816
91,184
Operating income or loss
-66,815
-66,815
-115,139
-191,816
-91,184
Total other income/expenses net
4,808
4,808
2,127
-220
54
Income before tax
-62,007
-62,007
-113,012
-192,036
-91,130
Income from continuing operations
-62,007
-62,007
-113,012
-192,036
-91,130
Net income
-62,007
-62,007
-113,012
-192,036
-91,130
Net income available to common shareholders
-62,007
-62,007
-113,012
-192,036
-91,130
Basic EPS
-42.42
-
-62.77
-109.08
-69.46
Diluted EPS
-42.42
-
-62.77
-109.08
-69.46
Basic average shares
1,790
-
1,800
1,761
1,312
Diluted average shares
1,790
-
1,800
1,761
1,312